Kostakoglu, L. Et Al. 1997. Clinical validation of the influence of p-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors. JOURNAL OF NUCLEAR MEDICINE , vol.38, no.7 , 1003-1008.

Kostakoglu, L., Elahi, N., Kiratli, P., Ruacan, S., Sayek, I., Baltali, E., ... Sungur, A.(1997). Clinical validation of the influence of p-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors. JOURNAL OF NUCLEAR MEDICINE , vol.38, no.7, 1003-1008.

Kostakoglu, L Et Al. "Clinical validation of the influence of p-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors," JOURNAL OF NUCLEAR MEDICINE , vol.38, no.7, 1003-1008, 1997

Kostakoglu, L Et Al. "Clinical validation of the influence of p-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors." JOURNAL OF NUCLEAR MEDICINE , vol.38, no.7, pp.1003-1008, 1997

Kostakoglu, L. Et Al. (1997) . "Clinical validation of the influence of p-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors." JOURNAL OF NUCLEAR MEDICINE , vol.38, no.7, pp.1003-1008.

@article{article, author={L Kostakoglu Et Al. }, title={Clinical validation of the influence of p-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors}, journal={JOURNAL OF NUCLEAR MEDICINE}, year=1997, pages={1003-1008} }